These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 18658093)
41. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737 [TBL] [Abstract][Full Text] [Related]
42. [Isolation and function analysis of rat CD4+ CD25+ regulatory T cells]. Lu L; Zhang F; Wang XH; Pu LY; Yao AH; Yu Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):417-9. PubMed ID: 16805996 [TBL] [Abstract][Full Text] [Related]
43. [Suppressive effect of induced CD4+CD25+ regulatory T cells from mice infected with Schistosoma japonicum]. Tan MJ; Zhang YC; Wang Y; Hu W; Liang YJ; Zhang L Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):166-9, 173. PubMed ID: 19160959 [TBL] [Abstract][Full Text] [Related]
44. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Saruta M; Yu QT; Fleshner PR; Mantel PY; Schmidt-Weber CB; Banham AH; Papadakis KA Clin Immunol; 2007 Dec; 125(3):281-90. PubMed ID: 17897887 [TBL] [Abstract][Full Text] [Related]
45. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694 [TBL] [Abstract][Full Text] [Related]
46. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules. Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201 [TBL] [Abstract][Full Text] [Related]
47. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
48. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Valzasina B; Piconese S; Guiducci C; Colombo MP Cancer Res; 2006 Apr; 66(8):4488-95. PubMed ID: 16618776 [TBL] [Abstract][Full Text] [Related]
49. Depleting anti-CD4 monoclonal antibody (GK1.5) treatment: influence on regulatory CD4+CD25+Foxp3+ T cells in mice. Yi H; Zhen Y; Zeng C; Zhang L; Zhao Y Transplantation; 2008 Apr; 85(8):1167-74. PubMed ID: 18431238 [TBL] [Abstract][Full Text] [Related]
50. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011 [TBL] [Abstract][Full Text] [Related]
51. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance. Jiang S; Tsang J; Lechler RI Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221 [TBL] [Abstract][Full Text] [Related]
52. Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions. Okui T; Ito H; Honda T; Amanuma R; Yoshie H; Yamazaki K Oral Microbiol Immunol; 2008 Feb; 23(1):49-54. PubMed ID: 18173798 [TBL] [Abstract][Full Text] [Related]
53. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698 [TBL] [Abstract][Full Text] [Related]
54. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984 [TBL] [Abstract][Full Text] [Related]
55. Expression of the Foxp3 gene in spleen mononuclear cells of a mouse model with allergic rhinitis. Han D; Xi L; Fan E; Li Y; Zhang L ORL J Otorhinolaryngol Relat Spec; 2009; 71(6):317-22. PubMed ID: 20029241 [TBL] [Abstract][Full Text] [Related]
56. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells. Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524 [TBL] [Abstract][Full Text] [Related]
57. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties. Merlo A; Tagliabue E; Mènard S; Balsari A Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349 [TBL] [Abstract][Full Text] [Related]
58. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts. Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256 [TBL] [Abstract][Full Text] [Related]
59. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive. Qiao M; Thornton AM; Shevach EM Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157 [TBL] [Abstract][Full Text] [Related]
60. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells. Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]